Latest Earnings Results: Q3 '26
Estimated EPS
-$2.90
Reported EPS
---
Surprise
---
Estimated Rev
$17.97M
Reported Rev
---
Surprise
---
Pelthos Therapeutics Inc. reported net product revenues of $15.4 million for the three months ended June 30, 2026, and $26.1 million for the six months ended June 30, 2026.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | -- | -$6.87 | -- | N/A |
Q3 '26 | -$2.90 | -- | -- | N/A |
Q2 '26 | -$2.82 | -$6.62 | -134.87% | MISSED |
Q1 '26 | -$3.45 | -$3.09 | 10.43% | BEAT |
Q4 '25 | -$3.70 | -$6.87 | -85.84% | MISSED |